Telemedicine Adoption in an NCI-Designated Cancer Center During the COVID-19 Pandemic: A Report on Patient Experience of Care

Author:

Patel Krupal B.12,Alishahi Tabriz Amir3,Turner Kea3,Gonzalez Brian D.3,Oswald Laura B.3,Jim Heather S.L.3,Nguyen Oliver T.3,Hong Young-Rock4,Aldawoodi Nasrin5,Cao Biwei6,Wang Xuefeng6,Rollison Dana E.7,Robinson Edmondo J.89,Naso Cristina10,Spiess Philippe E.1011

Affiliation:

1. Department of Head and Neck and Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida

2. Department of Otolaryngology–Head and Neck Surgery, University of South Florida, Tampa, Florida

3. Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida

4. Department of Health Services Research, Management and Policy, College of Public Health and Health Professions, University of Florida, Gainesville, Florida

5. Department of Anesthesia, Moffitt Cancer Center, Tampa, Florida

6. Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida

7. Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida

8. Department of Internal and Hospital Medicine, Moffitt Cancer Center, Tampa, Florida

9. Center for Digital Health, Moffitt Cancer Center, Tampa, Florida

10. Virtual Health Program, Moffitt Cancer Center, Tampa, Florida

11. Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida

Abstract

Background: Patients with cancer require timely access to care so that healthcare providers can prepare an optimal treatment plan with significant implications for quality of life and mortality. The COVID-19 pandemic spurred rapid adoption of telemedicine in oncology, but study of patient experience of care with telemedicine in this population has been limited. We assessed overall patient experience of care with telemedicine at an NCI-designated Comprehensive Cancer Center during the COVID-19 pandemic and examined changes in patient experience over time. Patients and Methods: This was a retrospective study of outpatient oncology patients who received treatment at Moffitt Cancer Center. Press Ganey surveys were used to assess patient experience. Data from patients with appointments between April 1, 2020, and June 30, 2021, were analyzed. Patient experience was compared between telemedicine and in-person visits, and patient experience with telemedicine over time was described. Results: A total of 33,318 patients reported Press Ganey data for in-person visits, and 5,950 reported Press Ganey data for telemedicine visits. Relative to patients with in-person visits, more patients with telemedicine visits gave higher satisfaction ratings for access (62.5% vs 75.8%, respectively) and care provider concern (84.2% vs 90.7%, respectively) (P<.001). When adjusted for age, race/ethnicity, sex, insurance, and clinic type, telemedicine visits consistently outperformed in-person visits over time regarding access and care provider concern (P<.001). There were no significant changes over time in satisfaction with telemedicine visits regarding access, care provider concern, telemedicine technology, or overall assessment (P>.05). Conclusions: In this study, a large oncology dataset showed that telemedicine resulted in better patient experience of care in terms of access and care provider concern compared with in-person visits. Patient experience of care with telemedicine visits did not change over time, suggesting that implementing telemedicine was effective.

Publisher

Harborside Press, LLC

Subject

Oncology

Reference53 articles.

1. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China;Liang W,2020

2. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group;Al-Shamsi HO,2020

3. Meeting patients where they are: policy platform for telehealth and cancer care delivery;Kircher S,2021

4. Opportunities and barriers for telemedicine in the U.S. during the COVID-19 emergency and beyond;Weigel G

5. Telemedicine for cancer care in the time of COVID-19;Royce TJ,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3